215 related articles for article (PubMed ID: 9865811)
1. Depression and stimulant dependence: neurobiology and pharmacotherapy.
Kosten TR; Markou A; Koob GF
J Nerv Ment Dis; 1998 Dec; 186(12):737-45. PubMed ID: 9865811
[TBL] [Abstract][Full Text] [Related]
2. Neurobiological similarities in depression and drug dependence: a self-medication hypothesis.
Markou A; Kosten TR; Koob GF
Neuropsychopharmacology; 1998 Mar; 18(3):135-74. PubMed ID: 9471114
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of antidepressants in substance use disorders with and without comorbid depression. A systematic review and meta-analysis.
Torrens M; Fonseca F; Mateu G; Farré M
Drug Alcohol Depend; 2005 Apr; 78(1):1-22. PubMed ID: 15769553
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant treatment of co-occurring depression and alcohol dependence.
Pettinati HM
Biol Psychiatry; 2004 Nov; 56(10):785-92. PubMed ID: 15556124
[TBL] [Abstract][Full Text] [Related]
5. Use of Antidepressants in Patients with Co-occurring Depression and Substance Use Disorders.
Carey TL
Handb Exp Pharmacol; 2019; 250():359-370. PubMed ID: 30244298
[TBL] [Abstract][Full Text] [Related]
6. The neurobiology of antidepressants.
Blows WT
J Neurosci Nurs; 2000 Jun; 32(3):177-80. PubMed ID: 10907206
[TBL] [Abstract][Full Text] [Related]
7. The role of dopamine and norepinephrine in depression and antidepressant treatment.
Nutt DJ
J Clin Psychiatry; 2006; 67 Suppl 6():3-8. PubMed ID: 16848670
[TBL] [Abstract][Full Text] [Related]
8. Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence.
Extein IL; Gold MS
J Addict Dis; 1993; 12(3):29-43. PubMed ID: 7504527
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of the dopaminergic system as a key component to the understanding of depression.
Yadid G; Friedman A
Prog Brain Res; 2008; 172():265-86. PubMed ID: 18772037
[TBL] [Abstract][Full Text] [Related]
10. Proposal for a bipolar-stimulant spectrum: temperament, diagnostic validation and therapeutic outcomes with mood stabilizers.
Camacho A; Akiskal HS
J Affect Disord; 2005 Mar; 85(1-2):217-30. PubMed ID: 15780692
[TBL] [Abstract][Full Text] [Related]
11. Animal models of depression: parallels and correlates to severe depression in humans.
Jesberger JA; Richardson JS
Biol Psychiatry; 1985 Jul; 20(7):764-84. PubMed ID: 2860930
[TBL] [Abstract][Full Text] [Related]
12. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
Thomas SJ; Shin M; McInnis MG; Bostwick JR
Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
[TBL] [Abstract][Full Text] [Related]
13. Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.
Grabowski J; Shearer J; Merrill J; Negus SS
Addict Behav; 2004 Sep; 29(7):1439-64. PubMed ID: 15345275
[TBL] [Abstract][Full Text] [Related]
14. The use of dopaminergic and stimulant drugs for the treatment of depression.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2012 Feb; 50(2):11-4. PubMed ID: 22263621
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic agents and stimulants as antidepressant augmentation strategies.
Nierenberg AA; Dougherty D; Rosenbaum JF
J Clin Psychiatry; 1998; 59 Suppl 5():60-3; discussion 64. PubMed ID: 9635549
[TBL] [Abstract][Full Text] [Related]
16. [The central dopaminergic system and depression].
Ebert D; Lammers CH
Nervenarzt; 1997 Jul; 68(7):545-55. PubMed ID: 9333715
[TBL] [Abstract][Full Text] [Related]
17. [The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].
Ströhle A
Nervenarzt; 2003 Mar; 74(3):279-91; quiz 292. PubMed ID: 12627245
[TBL] [Abstract][Full Text] [Related]
18. Antidepressant drug studies in the elderly.
Rockwell E; Lam RW; Zisook S
Psychiatr Clin North Am; 1988 Mar; 11(1):215-33. PubMed ID: 2898134
[TBL] [Abstract][Full Text] [Related]
19. The serotonin-dopamine interaction is critical for fast-onset action of antidepressant treatment: in vivo studies in an animal model of depression.
Dremencov E; Gispan-Herman I; Rosenstein M; Mendelman A; Overstreet DH; Zohar J; Yadid G
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):141-7. PubMed ID: 14687868
[TBL] [Abstract][Full Text] [Related]
20. Animal models and treatments for addiction and depression co-morbidity.
Paterson NE; Markou A
Neurotox Res; 2007 Jan; 11(1):1-32. PubMed ID: 17449445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
